INTIO adresses the emerging field of oncologic interventions. Its FDA cleared system is a platform technology addressing a $1.9B market.
INTIO has developed a powerful computer system to address the oncology market for tumor imaging. SVM’s applications include accurate volumes for RT, IO and response assessment for systemic therapies. Its performance exceeds all existing 3D applications having been validated in explant studies. Its customers include all hospitals and imaging centers involved with cancer imaging and therapy with initial focus on the top 100 cancer centers in the US